vs
Side-by-side financial comparison of BioLineRx Ltd. (BLRX) and SMITH MICRO SOFTWARE, INC. (SMSI). Click either name above to swap in a different company.
BioLineRx Ltd. is the larger business by last-quarter revenue ($5.4M vs $4.0M, roughly 1.4× SMITH MICRO SOFTWARE, INC.).
BioLineRx Ltd., or BioLine, is a publicly traded drug development company. Headquartered in Israel, its shares are traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange.
Smith Micro Software, Inc., founded in 1982 by William W. Smith, Jr., is a developer and marketer of both enterprise and consumer-level software and services. Headquartered in Pittsburgh, Pennsylvania, Smith Micro maintains multiple domestic and international offices. United States locations include Aliso Viejo, California, and Pittsburgh, Pennsylvania. International offices are located throughout Europe and Asia. Currently, the company focuses on digital lifestyle solutions and security tech...
BLRX vs SMSI — Head-to-Head
Income Statement — Q2 FY2024 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $5.4M | $4.0M |
| Net Profit | $484.0K | — |
| Gross Margin | 83.4% | 76.4% |
| Operating Margin | -107.0% | -109.8% |
| Net Margin | 9.0% | — |
| Revenue YoY | — | -20.0% |
| Net Profit YoY | 102.6% | — |
| EPS (diluted) | $0.00 | $-0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $4.0M | ||
| Q3 25 | — | $4.3M | ||
| Q2 25 | — | $4.4M | ||
| Q1 25 | — | $4.6M | ||
| Q4 24 | — | $5.0M | ||
| Q3 24 | — | $4.6M | ||
| Q2 24 | $5.4M | $5.1M | ||
| Q1 24 | — | $5.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | $-4.5M | ||
| Q2 25 | — | $-15.1M | ||
| Q1 25 | — | $-5.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-6.4M | ||
| Q2 24 | $484.0K | $-6.9M | ||
| Q1 24 | — | $-31.0M |
| Q4 25 | — | 76.4% | ||
| Q3 25 | — | 73.9% | ||
| Q2 25 | — | 73.5% | ||
| Q1 25 | — | 72.8% | ||
| Q4 24 | — | 75.6% | ||
| Q3 24 | — | 71.6% | ||
| Q2 24 | 83.4% | 68.7% | ||
| Q1 24 | — | 65.7% |
| Q4 25 | — | -109.8% | ||
| Q3 25 | — | -103.2% | ||
| Q2 25 | — | -338.3% | ||
| Q1 25 | — | -112.7% | ||
| Q4 24 | — | -89.7% | ||
| Q3 24 | — | -140.0% | ||
| Q2 24 | -107.0% | -135.8% | ||
| Q1 24 | — | -542.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | -104.3% | ||
| Q2 25 | — | -340.8% | ||
| Q1 25 | — | -112.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -137.0% | ||
| Q2 24 | 9.0% | -134.8% | ||
| Q1 24 | — | -534.8% |
| Q4 25 | — | $-0.15 | ||
| Q3 25 | — | $-0.25 | ||
| Q2 25 | — | $-0.78 | ||
| Q1 25 | — | $-0.28 | ||
| Q4 24 | — | $0.54 | ||
| Q3 24 | — | $-0.54 | ||
| Q2 24 | $0.00 | $-0.66 | ||
| Q1 24 | — | $-3.28 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $9.6M | $1.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $13.9M | $18.4M |
| Total Assets | $64.6M | $25.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $1.5M | ||
| Q3 25 | — | $1.4M | ||
| Q2 25 | — | $1.4M | ||
| Q1 25 | — | $2.3M | ||
| Q4 24 | — | $2.8M | ||
| Q3 24 | — | $1.5M | ||
| Q2 24 | $9.6M | $5.6M | ||
| Q1 24 | — | $6.2M |
| Q4 25 | — | $18.4M | ||
| Q3 25 | — | $19.9M | ||
| Q2 25 | — | $22.4M | ||
| Q1 25 | — | $36.6M | ||
| Q4 24 | — | $40.8M | ||
| Q3 24 | — | $37.7M | ||
| Q2 24 | $13.9M | $42.9M | ||
| Q1 24 | — | $45.4M |
| Q4 25 | — | $25.0M | ||
| Q3 25 | — | $27.1M | ||
| Q2 25 | — | $29.6M | ||
| Q1 25 | — | $43.4M | ||
| Q4 24 | — | $48.0M | ||
| Q3 24 | — | $46.2M | ||
| Q2 24 | $64.6M | $53.0M | ||
| Q1 24 | — | $55.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-25.4M | $-2.2M |
| Free Cash FlowOCF − Capex | $-25.5M | — |
| FCF MarginFCF / Revenue | -472.8% | — |
| Capex IntensityCapex / Revenue | 1.1% | — |
| Cash ConversionOCF / Net Profit | -52.56× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-2.2M | ||
| Q3 25 | — | $-2.1M | ||
| Q2 25 | — | $-2.3M | ||
| Q1 25 | — | $-602.0K | ||
| Q4 24 | — | $-4.9M | ||
| Q3 24 | — | $-3.8M | ||
| Q2 24 | $-25.4M | $-4.2M | ||
| Q1 24 | — | $-1.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | $-2.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $-606.0K | ||
| Q4 24 | — | $-4.9M | ||
| Q3 24 | — | $-3.8M | ||
| Q2 24 | $-25.5M | $-4.2M | ||
| Q1 24 | — | $-1.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | -49.6% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -13.1% | ||
| Q4 24 | — | -99.2% | ||
| Q3 24 | — | -82.2% | ||
| Q2 24 | -472.8% | -82.0% | ||
| Q1 24 | — | -23.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.5% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | 1.1% | 0.1% | ||
| Q1 24 | — | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -52.56× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BLRX
Segment breakdown not available.
SMSI
| Family Safety | $3.2M | 80% |
| Other | $797.0K | 20% |
